aap Implantate AG

aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights

aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages

aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028

aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights

aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier

After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year

More than 100 patients included in the human clinical trial by 31 December 2023; adapted study design meets expectations for accelerated patient recruitment

aap concludes distribution agreement for LOQTEQ® VA Radius System with leading global spine and orthopedics company

Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation of a personnel measure to achieve positive EBITDA and balanced cash flow in the operating trauma business

Visible acceleration in clinical trial with already more than 60 patients; increase in funding of around EUR 0.4 million underscores innovative strength of silver coating technology

aap Implantate AG: Deepblue Holding AG, Subscription of partial bonds in the context of the private placement for a convertible bond

aap Implantate AG: Nino Buckow, Subscription of partial bonds in the context of the private placement for a convertible bond

aap Implantate AG: Agnieszka Mierzejewska, Subscription of partial bonds in the context of the private placement for a convertible bond

aap Implantate AG: Merval AG, Subscription of partial bonds in the context of the private placement for a convertible bond

aap Implantate AG: Deepblue Holding AG, Exercise of subscription rights in the context of a subscription offer for a convertible bond

aap Implantate AG: Agnieszka Mierzejewska, Exercise of subscription rights in the context of a subscription offer for a convertible bond)

aap Implantate AG: Nino Buckow, Exercise of subscription rights in the context of a subscription offer for a convertible bond)

aap Implantate AG: Merval AG, Exercise of subscription rights in the context of a subscription offer for a convertible bond)

aap places mandatory convertible bond 2023/2028 in the amount of EUR 2.5 million

aap Implantate AG: Rubino di Girolamo, Granting of 60,817 subscription rights as part of a subscription offer for a convertible bond

aap Implantate AG: Marek Hahn, Granting of 47,364 subscription rights as part of a subscription offer for a convertible bond

aap Implantate AG: Deepblue Holding AG, Granting of 334,496 subscription rights as part of a subscription offer for a convertible bond

aap Implantate AG: Langner Asset Management GmbH, Granting of 10,000 subscription rights as part of a subscription offer for a convertible bond

aap Implantate AG: Jürgen Krebs, Granting of 272,495 subscription rights as part of a subscription offer for a convertible bond

aap Implantate AG: Agnieszka Mierzejewska, Granting of 19,143 subscription rights as part of a subscription offer for a convertible bond